[Immunotherapy with Broncho-Vaxom in the treatment and prevention of recurrent inflammations of the respiratory system]. 1984

B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
March 1987, Fortschritte der Medizin,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
June 1986, Pneumonologia polska,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
November 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
January 1992, Pneumonologia i alergologia polska,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
January 2018, International immunopharmacology,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
January 1994, Otolaryngologia polska = The Polish otolaryngology,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
January 1992, Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
January 1987, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
June 1984, Schweizerische medizinische Wochenschrift,
B Král, and M Tichý, and B Fixa, and J Eliás, and A Ilnerová
August 1958, Casopis lekaru ceskych,
Copied contents to your clipboard!